News

Olivier Elemento, Ph.D., and colleagues describe their data model that links variants to both tumor- and tissue-specific interpretations. Read more

Peter Martin, M.D., comments on the results of a new immunochemotherapy regimen for the treatment of mantle cell lymphoma. Read more

Marcin Imielinski, M.D., Ph.D., discusses the potential of precision medicine or cancer care. Read more

Certain types of cancer may be even more shifty and difficult to target than previously thought, due to continuous changes in cell programming. Read more

Despite very promising pre-clinical results and some clinical success, there is still much need to generate solid evidence demonstrating the efficacy of combining radiation with immunotherapy, according to Silvia Formenti, M.D., and Sandra Demaria, M.D. Read more

Lisa Roth, M.D., on running a race on behalf of a patient and herself, as a lymphoma survivor. Read more

Ana Molina, M.D., comments on a new treatment for kidney cancer. Read more

A drug that recruits immune cells to fight an aggressive form of lymphoma that disproportionately affects minorities in the United States appears to be more effective than chemotherapy, according to Adrienne Phillips, M.D. Read more

Profile of Rohan Ramakrishna, M.D., and some of the novel methods he is using to tackle brain tumors. Read more